Matches in Nanopublications for { ?s ?p "[MET activation confers a selective advantage to neoplastic cells in tumor progression and drug resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP617803.RAroCfTxzAFAaZpaz0bb3vZl89bKQTtV6bmihQ-RfLZpA130_assertion description "[MET activation confers a selective advantage to neoplastic cells in tumor progression and drug resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP617803.RAroCfTxzAFAaZpaz0bb3vZl89bKQTtV6bmihQ-RfLZpA130_provenance.
- NP802977.RAUyvZKfPssPJziay7xkZqIeUdwKe3WQHGFwF3qwkVuyQ130_assertion description "[MET activation confers a selective advantage to neoplastic cells in tumor progression and drug resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802977.RAUyvZKfPssPJziay7xkZqIeUdwKe3WQHGFwF3qwkVuyQ130_provenance.
- assertion description "[MET activation confers a selective advantage to neoplastic cells in tumor progression and drug resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP841651.RAlBe2HDjfT84VUa1F82xsYqbpRVJJhaMc0UNd-ZR5yo8130_assertion description "[MET activation confers a selective advantage to neoplastic cells in tumor progression and drug resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP841651.RAlBe2HDjfT84VUa1F82xsYqbpRVJJhaMc0UNd-ZR5yo8130_provenance.
- NP841653.RAkvU3PHsFQjtba9ezPzw5F1zRy8_vzllwm3JlhOIKfQA130_assertion description "[MET activation confers a selective advantage to neoplastic cells in tumor progression and drug resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP841653.RAkvU3PHsFQjtba9ezPzw5F1zRy8_vzllwm3JlhOIKfQA130_provenance.
- NP945920.RAPGtoMfrYDXeDHqrKFUrizyyznKyVNgUQK7H9gVdHUXA130_assertion description "[MET activation confers a selective advantage to neoplastic cells in tumor progression and drug resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP945920.RAPGtoMfrYDXeDHqrKFUrizyyznKyVNgUQK7H9gVdHUXA130_provenance.
- NP841655.RA7GOtcQruVFWp-tkSgv3LZzkPlh8K5MaruaLVRaYttfE130_assertion description "[MET activation confers a selective advantage to neoplastic cells in tumor progression and drug resistance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP841655.RA7GOtcQruVFWp-tkSgv3LZzkPlh8K5MaruaLVRaYttfE130_provenance.